|1.||Tseveleki, Vivian: 2 articles (01/2014 - 12/2004)|
|2.||Baxter, Alan G: 2 articles (07/2011 - 01/2004)|
|3.||Moradi Tabriz, Hedieh: 1 article (08/2014)|
|4.||Arrefhosseini, Seyed Rafi: 1 article (08/2014)|
|5.||Alizadeh, Akram: 1 article (08/2014)|
|6.||Razeghi Jahromi, Soodeh: 1 article (08/2014)|
|7.||Togha, Mansoureh: 1 article (08/2014)|
|8.||Ghaemi, Amir: 1 article (08/2014)|
|9.||Kanistras, Ioannis: 1 article (01/2014)|
|10.||Gatos, Dimitrios: 1 article (01/2014)|
|1.||Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/22/2010 - "In this study, we immunized N-type Ca(2+) channel α(1B)-deficient (α(1B)(-/-)) mice and their wild type (WT) littermates with myelin oligodendrocyte glycoprotein 35-55 and analyzed the progression of experimental autoimmune encephalomyelitis (EAE). "
10/01/2006 - "To address whether CCR7 plays a role in the development of autoimmunity, we induced experimental autoimmune encephalomyelitis in CCR7-deficient mice on a C57BL/6 background (CCR7(-/-)) using the neuroantigen, myelin oligodendrocyte glycoprotein 35-55 amino acid peptide (MOG((35-55))) and Bordetella pertussis toxin (PTX). "
12/01/2004 - "In addition to showing augmented Th2-type responses, TgFLIP(L) mice are resistant to the development of myelin oligodendrocyte glycoprotein 35-55 peptide-induced experimental autoimmune encephalomyelitis, a Th1-driven autoimmune disease. "
08/01/2009 - "The aim of this study was to determine the therapeutic effect of Periplocoside A (PSA), a natural product isolated from the traditional Chinese herbal medicine Periploca sepium Bge, in MOG(35-55) (myelin oligodendrocyte glycoprotein 35-55)-induced experimental autoimmune encephalomyelitis (EAE). "
01/01/2014 - "Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in mice."
03/31/2011 - "Whereas no clinical signs could be found by immunization with myelin oligodendrocyte glycoprotein 35-55, significant weight loss as well as rapidly occurring severe ascending paralysis was found in animals immunized with proteolipid protein 190-209 (PLP(190-209)). "
01/01/2004 - "First, the CNS autoantigen myelin oligodendrocyte glycoprotein 35-55, when applied repeatedly with cholera toxin to the intact skin of healthy C57BL/6 mice, induced relapsing paralysis with demyelinating immunopathologic features similar to multiple sclerosis. "
|4.||Weight Loss (Weight Reduction)
|5.||Optic Neuritis (Retrobulbar Neuritis)
|2.||Dimethyl Sulfoxide (DMSO)
|5.||Glia Maturation Factor (GMF)
|6.||HLA-DR2 Antigen (HLA DR2 Antigen)